AIDS
Conditions
Interventions
Experimental group:NK Cell Infusion
Sponsors
NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-60 years; 2. HIV serum antibody was positive; 3. With ART more than 6 months and the viral load is lower than < 20 copies/ml; 4. No severe liver, heart and kidney dysfunction; 5. Fully understand the purpose, methods and possible side effects of the trial, and voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criteria will not be included in this study. 1. Patients with severe opportunistic infection or tumor; 2. Patients with active hepatitis B, hepatitis C, syphilis, cytomegalovirus, EB virus or HSV-1 and HSV-2; 3. Suffering from more serious chronic diseases, metabolic diseases, neurological and mental diseases; 4. Patients with previous pancreatitis; 5. Suspected or confirmed history of alcoholism, smoking and drug abuse; 6. Patients participating in any other experimental drug study or received radiotherapy, chemotherapy and nuclear medicine examination in the past three months; 7. Intravenous injection is not acceptable; 8. Weak body, low compliance, or other conditions that failure to comply with the research requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital Signs;CD4 T Cell Count;HIV Reservoir;NK cell number and function;Cytokines;Adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine Blood Test;Blood Biochemistry;Routine urine test; | — |
Countries
China
Contacts
Public ContactHui Zhang
NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical University
Outcome results
None listed